Tempsens Instruments shares surged 17% on Tuesday, extending gains to about 89% above their ₹300 IPO price. First-half FY27 revenue rose 33.7% year-on-year, but higher employee costs and expansion investments reduced EBITDA margins to 21.2% from 25.2%.Tempsens Instruments shares surged 17% on Tuesday, extending gains to about 89% above their ₹300 IPO price. First-half FY27 revenue rose 33.7% year-on-year, but higher employee costs and expansion investments reduced EBITDA margins to 21.2% from 25.2%.
